VC-backed JenaValve Technology names CTO
JenaValve Technology has hired Dr. Stefan Schreck as chief technology officer. The apointment is effective immediately. Schreck is the former vice president of technology and later chief technology officer at Endologix. Based in Munich, Germany and Irvine, Calif., JenaValve Technology is a provider of transcatheter aortic valve implantation systems that treat aortic valve disease. Its backers include Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
12 August 2014•3 mins read
